NewsBenzinga식스스 스트리트, 경쟁사 거래 지연 속 브라이트하우스 인수 제안 재개 - 블룸버그 식스스 스트리트, 경쟁사 거래 지연 속 브라이트하우스 인수 제안 재개 - 블룸버그 Benzinga 2026.09.22 20:07 (GMT+0) Open on Benzinga Other news Canaccord Genuity Maintains Buy on Belite Bio, Raises Price Target to $314 Applied Optoelectronics Stock Sinks Amid AI Outlook Fears Canaccord Genuity Maintains Buy on Enovix, Lowers Price Target to $2.5 Canaccord Genuity Maintains Buy on Intuitive Machines, Lowers Price Target to $38 'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report Canaccord Genuity Maintains Buy on Nektar Therapeutics, Lowers Price Target to $149
'A Zelle representative said that a technical issue on its platform originated with Chase' -NBC Report